Which drug info are worth shortlisting in 2026?
3 tools survived our 2026 review for clinical use: UpToDate Lexidrug for drug reference; Epocrates for clinician drug app; Drugs.com Professional for public + pro.
3 tools we actually recommend
Each pick wins a specific use case. The wrong question is “which is best”. The right question is “which fits my situation”. Skip past the ones not matching yours.
by Wolters Kluwer
Tracked· 17Most-deployed drug reference in US health systems. Formerly Lexicomp.
Wolters Kluwer. Drug-drug, drug-allergy, IV-compatibility screening. Institutional standard.
- No public price, contact form only. Personal subscriptions are also sold (mobile app and store.uptodate.com), but the current personal price is not confirmed.
- —
by Epocrates (athenahealth)
Solid choice· 46Most-used clinician drug-reference app in the US, free tier.
Free + $16.99/mo Plus + $159/yr Essentials. Pill ID, formulary, interactions.
- $24.99/mo from
- —
by Drugsite Trust
Tracked· 12Strong free public tier + Pro $285/yr.
Drug database + interactions + IV compatibility + pill ID.
- Free to use with a free sign-up to save drug and interaction lists. Funded by advertising. No Pro subscription or price was found.
- —
What should clinicians look for when buying drug info?
The right tool depends on your workflow, your specialty, your budget, and your scale. Five criteria do most of the work narrowing your shortlist.
Workflow integration depth
How deeply does it sit inside your existing workflow? Tools that require copy-paste eventually get abandoned. Tools with native bidirectional sync into your EHR or platform stay.
HIPAA + compliance attestation
Non-negotiable for any clinical use. Look for explicit HIPAA + SOC2 + signed BAA. Free general-purpose LLMs are NOT compliant out-of-the-box.
Pricing transparency
Vendors that publish per-seat or per-encounter pricing on their site are easier to evaluate than enterprise-only quotes. If you can't get pricing without a sales call, factor that friction in.
Specialty and language fit
Performance varies materially by specialty and patient population. Aggregated reviews often look fine but mask specialty-level variance. Pilot in your own workflow before committing.
Vendor stability
This is a multi-year commitment in practice. Funding stage, leadership continuity, enterprise references, and platform partnerships matter. Pre-Series-B vendors carry more risk.
Some outbound links below are affiliate links. We may earn a commission when you sign up, at no extra cost to you. Rankings are editorial and never sold. Full policy at /affiliate-disclosure.
How do all 8 tools compare side-by-side?
Pricing from vendor documentation, certifications verified against public attestations. Highlighted rows were directly evaluated by an MD on our editorial team within the past six months.
| Ref | Tool | From | Score | Compliance / EHR | Founded | Action |
|---|---|---|---|---|---|---|
| DI-001 |  Elsevier | Available by subscription only. No public price. A free trial can be requested, length not stated. | 12/100Tracked | — | Visit | |
| DI-002 |  Drugsite Trust | Free to use with a free sign-up to save drug and interaction lists. Funded by advertising. No Pro subscription or price was found. | 12/100Tracked | — | Visit | |
| DI-003 |  Epocrates (athenahealth) | $24.99/mo | 46/100Solid choice | 1998 | Visit | |
| DI-004 | Wolters Kluwer | No public price. | 10/100Tracked | — | Visit | |
| DI-005 | Free to use per third-party sources (registration may be required). The Medscape page itself states no price. | 29/100Niche fit | — | Visit | ||
| DI-006 |  Merative | No public price, quoted per organization. No current individual subscription was found. | 28/100Niche fit | — | Visit | |
| DI-007 | Skyscape Medpresso | Free download with in-app purchases per the app stores, not re-verified (the App Store fetch returned HTTP 429). The vendor homepage shows no price. | 6/100Tracked | — | Visit | |
| DI-008 | Wolters Kluwer | No public price, contact form only. Personal subscriptions are also sold (mobile app and store.uptodate.com), but the current personal price is not confirmed. | 17/100Tracked | — | Visit |
Scroll horizontally to see all columns.
What do clinicians ask about drug info?
Sourced from clinical pharmacists, formulary committees, and clinician drug-reference user feedback.
Browse all questionsDeeper articles
Suki pricing in 2026: what practices and health systems actually pay
Suki publishes no price. Third parties report $299 to $399 per user per month, and $350 to $500+ on enterprise contracts, as of October 2026.
Ambience Healthcare pricing in 2026: what health systems actually pay
Ambience publishes no price and ties its fees to outcomes. Third-party estimates run about $233 to $417 per provider per month, as of October 2026.
Abridge pricing in 2026: what health systems actually pay
Abridge publishes no price. Third-party estimates run from about $208 to $600 per clinician per month, plus implementation, as of October 2026.